factual

Brand-Name Drug Spending Rose 62% Post-Rebate

Medicare spending on brand-name drugs rose 62% between 2011 and 2015 even after accounting for rebates, with the sharpest price increases on commonly-used medications for diabetes, high cholesterol, and asthma rather than only on rare-condition drugs.

factualpending

Speaker

Robin Feldman

Evidence Quote

“Medicare spending for brand-name drugs, even after accounting for rebates, still rose 62% between 2011 and 2015.”

Source

Robin Feldman on Drugs, Money, and Secret Handshakes— EconTalk
Created: 6/13/2026, 12:12:41 AM

Your notes

Loading notes...